Who founded Vascugen?

Vascugen was founded by Marvin Yoder, Mervin C. Yoder in 2017.

Who are Vascugen's investors?

Vascugen's investors include IU Ventures.

How much funding has Vascugen raised?

Vascugen has disclosed $10M raised across 1 of its 2 known rounds.

Where is Vascugen headquartered?

Vascugen is headquartered in Madison, US.

Vascugen

Madison, US · Founded 2017 · 1 known investors

Find your way into Vascugen

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vascugen team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.

Biotech Healthtech Longevity Medical Devices

Founders & leadership

Vascugen was founded in 2017 by Marvin Yoder and Mervin C. Yoder.

Marvin YoderCo-founder

Mervin C. YoderScientific Founder

Carter CliffNamed on SEC filing

Tom NovakNamed on SEC filing

Jeffrey KennedyNamed on SEC filing

Investors · 1

IU Ventureslisted by IU VenturesBloomington

How we know: IU Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 1 of 2 rounds · 2019–2020

▶$10MraisedAug 2020 · 6 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Marvin YoderDirector
Carter CliffExecutive Officer, Director
Tom NovakDirector
Jeffrey KennedyDirector

Offering amount: $10M
Amount sold: $10M
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Vascugen do?: Vascugen develops an induced-pluripotent stem cell (iPSC)-derived vasculogenic cell therapy intended to form new blood vessels and restore microvascular circulation in oxygen-starved tissues. It targets diabetic and arterial disease patients at high risk of limb amputation, and handles development from R&D through cGMP manufacturing.
Who founded Vascugen?: Vascugen was founded by Marvin Yoder, Mervin C. Yoder in 2017.
Who are Vascugen's investors?: Vascugen's investors include IU Ventures.
How much funding has Vascugen raised?: Vascugen has disclosed $10M raised across 1 of its 2 known rounds.
Where is Vascugen headquartered?: Vascugen is headquartered in Madison, US.